๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women

โœ Scribed by Sandra A. Norman; Jesse A. Berlin; Anita L. Weber; Brian L. Strom; Janet R. Daling; Linda K. Weiss; Polly A. Marchbanks; Leslie Bernstein; Lynda F. Voigt; Jill A. McDonald; Giske Ursin; Jonathan M. Liff; Ronald T. Burkman; Kathleen E. Malone; Michael S. Simon; Suzanne G. Folger; Dennis Deapen; Phyllis A. Wingo; Robert Spirtas

Book ID
111575426
Publisher
Springer Netherlands
Year
2003
Tongue
English
Weight
111 KB
Volume
14
Category
Article
ISSN
0957-5243

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Oral contraceptive use, hormone replacem
Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women
โœ Geoffrey C. Kabat; Anthony B. Miller; Thomas E. Rohan ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 69 KB ๐Ÿ‘ 2 views

## Abstract Evidence from epidemiologic studies suggests a possible role of exogenous and endogenous hormones in colorectal carcinogenesis in women. However, with respect to exogenous hormones, in contrast to hormone replacement therapy, few cohort studies have examined oral contraceptive use in re

Hormone replacement therapy and breast c
Hormone replacement therapy and breast cancer in former users of oral contraceptivesโ€”The Norwegian Women and Cancer study
โœ Eiliv Lund; Kjersti Bakken; Vanessa Dumeaux; Vegard Andersen; Merethe Kumle ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 66 KB ๐Ÿ‘ 2 views

## Abstract Combined estrogenโ€“progestin menopausal therapy (HRT) and combined estrogenโ€“progestin contraceptives (OC) both increase breast cancer risk during current use and a few years after. We investigated risk of breast cancer in women who were users of HRT dependant on former history of OC use